Celularity CELU
NASDAQ CELU
$1.38 +0.03 (+2.22%)
At close: Oct 1, 2026 · 4:00 PM EDT

Celularity (CELU) Interest Expenses (2025 - 2026)

Updated

Analysis

Celularity (CELU) Interest Expenses (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Celularity 39.39 Mn 31.87 Mn 2.39 Mn 352,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 352,000.00
Mar 31, 2025 2.44 Mn
API Access

Celularity Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=CELU&period=max&api_key=YOUR_API_KEY